ES2151502T3 - Complejos quelato y procedimientos para su obtencion. - Google Patents

Complejos quelato y procedimientos para su obtencion.

Info

Publication number
ES2151502T3
ES2151502T3 ES93810100T ES93810100T ES2151502T3 ES 2151502 T3 ES2151502 T3 ES 2151502T3 ES 93810100 T ES93810100 T ES 93810100T ES 93810100 T ES93810100 T ES 93810100T ES 2151502 T3 ES2151502 T3 ES 2151502T3
Authority
ES
Spain
Prior art keywords
complexes
chelato
procedures
obtaining
rutenio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93810100T
Other languages
English (en)
Spanish (es)
Inventor
Hans Georg Dr Capraro
Marcus Dr Baumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2151502T3 publication Critical patent/ES2151502T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/06—Aluminium compounds
    • C07F5/069—Aluminium compounds without C-aluminium linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds
    • C07F15/0053—Ruthenium compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0836—Compounds with one or more Si-OH or Si-O-metal linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polyethers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES93810100T 1992-02-27 1993-02-18 Complejos quelato y procedimientos para su obtencion. Expired - Lifetime ES2151502T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH60092 1992-02-27

Publications (1)

Publication Number Publication Date
ES2151502T3 true ES2151502T3 (es) 2001-01-01

Family

ID=4190744

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93810100T Expired - Lifetime ES2151502T3 (es) 1992-02-27 1993-02-18 Complejos quelato y procedimientos para su obtencion.

Country Status (22)

Country Link
US (3) US5358940A (enExample)
EP (1) EP0558449B1 (enExample)
JP (1) JPH0656839A (enExample)
KR (1) KR100270284B1 (enExample)
CN (1) CN1044476C (enExample)
AT (1) ATE196143T1 (enExample)
AU (1) AU662800B2 (enExample)
CA (1) CA2090772A1 (enExample)
DE (1) DE59310096D1 (enExample)
DK (1) DK0558449T3 (enExample)
ES (1) ES2151502T3 (enExample)
FI (1) FI930831A7 (enExample)
GR (1) GR3034887T3 (enExample)
HU (1) HUT64075A (enExample)
IL (1) IL104874A (enExample)
MX (1) MX9301083A (enExample)
NO (1) NO930719L (enExample)
NZ (1) NZ247000A (enExample)
PT (1) PT558449E (enExample)
SG (1) SG49615A1 (enExample)
TW (1) TW235298B (enExample)
ZA (1) ZA931382B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484778C1 (en) * 1990-07-17 2001-05-08 Univ Cleveland Hospitals Phthalocynine photosensitizers for photodynamic therapy and methods for their use
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
GB9123814D0 (en) * 1991-11-08 1992-01-02 Johnson Matthey Plc Photosensitizers
TW235298B (enExample) * 1992-02-27 1994-12-01 Ciba Geigy
GB9405970D0 (en) * 1994-03-25 1994-05-11 Secr Defence Substituted phthalocyanines
RU2106146C1 (ru) * 1995-07-17 1998-03-10 Институт элементоорганических соединений РАН Средство для подавления опухолевого роста
US5763602A (en) * 1996-10-01 1998-06-09 Li; Ying-Syi Methods of syntheses of phthalocyanine compounds
US5872248A (en) * 1997-03-28 1999-02-16 Case Western Reserve University Methods for inserting silicon into phthalocyanines and naphthalocyanines
IL121440A0 (en) 1997-07-31 1998-01-04 Yeda Res & Dev The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
MXPA01008951A (es) * 1999-03-05 2003-07-21 Univ Case Western Reserve Fotoblanqueadores liquidos hidrofobos.
US8211883B2 (en) * 2004-04-01 2012-07-03 Case Western Reserve University Topical delivery of phthalocyanines
US7153956B2 (en) * 2004-08-09 2006-12-26 Silverbrook Research Pty Ltd Cyanine dye having multifunctional peripheral groups
JP2010163473A (ja) * 2009-01-13 2010-07-29 Konica Minolta Business Technologies Inc インクジェット記録用シアンインク
US8440641B2 (en) * 2009-03-20 2013-05-14 Case Western Reserve University Phthalocyanine salt formulations
RU2682674C2 (ru) 2013-03-15 2019-03-20 Шерри Энн МАКФАРЛЭНД Координационные комплексы на основе металлов в качестве фотодинамических соединений и их применение
WO2019188118A1 (ja) * 2018-03-29 2019-10-03 パナソニックＩｐマネジメント株式会社 組成物、光電変換素子および撮像装置
JP6767695B2 (ja) * 2018-03-29 2020-10-14 パナソニックＩｐマネジメント株式会社 組成物、近赤外光電変換素子および撮像装置
CN121001958A (zh) * 2023-04-25 2025-11-21 佳能株式会社 单线态氧的产生方法、单线态氧的产生系统、单线态氧的产生试剂盒和单线态氧产生剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3094536A (en) * 1961-01-03 1963-06-18 Malcolm E Kenney Silicon phthalocyanines
US3094535A (en) * 1961-01-03 1963-06-18 Malcolm E Kenney Germanium phthalocyanines
CA1337194C (en) * 1988-04-07 1995-10-03 Koichi Kamijima Tetraazaporphin, process for producing the same, as well as optical recording media using the same and production processes thereof
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
DE3829851A1 (de) * 1988-09-02 1990-03-08 Basf Ag Tetraazaporphyrine sowie strahlungsempfindliche beschichtungsfilme
US5457195A (en) * 1989-12-21 1995-10-10 Board Of Regents, The University Of Texas System Sapphyrin derivatives and conjugates
ES2056617T3 (es) * 1990-04-03 1994-10-01 Ciba Geigy Ag Formulacion de liposomas, aplicable de forma parenteral, constituida por lipidos sinteticos.
ATE206124T1 (de) * 1990-05-15 2001-10-15 Diatron Corp Nachweisbar markierte markerverbindung mit einem fluorophor-rest , eine fluorescenz-probe mit der markerverbindung und verwendungen derselben.
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
US5403928A (en) * 1990-05-15 1995-04-04 Diatron Corporation Fluorescent marker components and fluorescent probes
US5166197A (en) * 1990-07-17 1992-11-24 Kenney Malcolm E Phthalocyanine photosensitizers for photodynamic therapy
US5260435A (en) * 1990-07-23 1993-11-09 Nippon Oil And Fats Co., Ltd. Derivative of naphthalocyanine containing perfluoroalkyl group, process for preparing the same and optical recording medium
GB9123814D0 (en) * 1991-11-08 1992-01-02 Johnson Matthey Plc Photosensitizers
TW235298B (enExample) * 1992-02-27 1994-12-01 Ciba Geigy

Also Published As

Publication number Publication date
PT558449E (pt) 2001-02-28
KR930017912A (ko) 1993-09-20
EP0558449B1 (de) 2000-09-06
TW235298B (enExample) 1994-12-01
AU3376893A (en) 1993-09-02
JPH0656839A (ja) 1994-03-01
DK0558449T3 (da) 2001-01-02
US5358940A (en) 1994-10-25
NZ247000A (en) 1995-07-26
FI930831A7 (fi) 1993-08-28
HU9300554D0 (en) 1993-05-28
ZA931382B (en) 1993-08-31
CN1044476C (zh) 1999-08-04
NO930719D0 (no) 1993-02-26
MX9301083A (es) 1993-09-01
CN1075966A (zh) 1993-09-08
FI930831A0 (fi) 1993-02-24
CA2090772A1 (en) 1993-08-28
HUT64075A (en) 1993-11-29
US5670491A (en) 1997-09-23
IL104874A (en) 1998-06-15
SG49615A1 (en) 2001-01-16
ATE196143T1 (de) 2000-09-15
DE59310096D1 (de) 2000-10-12
GR3034887T3 (en) 2001-02-28
AU662800B2 (en) 1995-09-14
IL104874A0 (en) 1993-06-10
US5686439A (en) 1997-11-11
EP0558449A1 (de) 1993-09-01
NO930719L (no) 1993-08-30
KR100270284B1 (ko) 2000-10-16

Similar Documents

Publication Publication Date Title
ES2151502T3 (es) Complejos quelato y procedimientos para su obtencion.
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
MX9200675A (es) Derivados de 2,4-diaminoquinazolinas para mejorar la actividad antitumoral.
ES2174895T3 (es) Combinaciones metalicas complejas con contenido en carbenos heterociclicos.
BG29132A3 (en) Method of obtaining of cyclohexan derivatives
ATA769376A (de) Boeschungssicherungsanordnung fuer die boeschung von daemmen, gelaendeeinschnitten und dgl.
ES2036809T3 (es) Variantes de la hirudina, sus utilizaciones y los procedimientos para obtenerlas.
SE7613588L (sv) Forfarande for framstellning av 3,4-dihydro-kinazolinderivat
ATE1500T1 (de) 6-chlor-2,3-dihydroxy-1,4-naphthochinon und seine 2,3-diester, und ihre herstellung.
ES523661A0 (es) Procedimiento para preparar fenoxipiridinas sulfuro-sustituidas teniendo actividad antiviral. desglose de la patente n 514.940.
ES2166900T3 (es) Derivados de ara-c.
IT1157701B (it) Perfezionamento nelle lampade per illuminazione subacquea e procedimento per la relativa fabbricazione
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
ATE149498T1 (de) Radicicol-derivate, ihre herstellung und ihre antitumorwirkung
ES467189A1 (es) Un procedimiento para la preparacion de nuevas pirroloquino-xalinonas y pirrolobenzodiazepinonas
IT1063073B (it) Utensile da taglio e relativo procedimento per aumentare la resistenza all'usura
FI830207A0 (fi) Pantenolderivat
FR2319364A1 (fr) Nouvelles diamino-2,4 (p-aminobenzyl)-5 pyrimidines, utiles notamment comme agents antibacteriens
SE8502865D0 (sv) Naphtoxazine, ihre herstellung und verwendung
IT1104110B (it) Perfezionamento nelle torri di raffreddamento
IT966750B (it) 2,2 bis oppure 2,2,2 tris 5,6 diidro 4h i,3 ossazine e procedimento per produrle
IT8422224A0 (it) Amminoantrachinoni cis-platino complessi e loro impiego come agenti antitumorali.
TR18913A (tr) S-suebstitueye 5-triflorometil-1,3,4-tiadiazoller,bunlarin,hazirlanisina ait usuller ve bunlarin fungisidler ve ensektisidler olarak kullanilmalari
NO870398D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive organiskeplatinakomplekser.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 558449

Country of ref document: ES